封面
市場調查報告書
商品編碼
1383636

馬保健市場 - 全球產業規模、佔有率、趨勢、機會和預測,2018-2028 年按產品、適應症、活動、配銷通路、地區、競爭預測和機會細分,2018-2028 年

Equine Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Indication, By Activity, By Distribution Channel, By Region, By Competition Forecast & Opportunities, 2018-2028F

出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年全球馬保健市場價值為 25.2 億美元,預計在預測期內將出現令人印象深刻的成長,到 2028 年CAGR為5.94%。全球馬保健市場是指致力於馬匹健康和福祉的行業。馬匹。它涵蓋廣泛的產品和服務,旨在維持和改善馬匹的健康,無論是出於娛樂還是競技目的。

主要市場促進因素

馬術運動和活動的參與度不斷提高

市場概況
預測期 2024-2028
2022 年市場規模 25.2億美元
2028 年市場規模 35.5億美元
2023-2028 年CAGR 5.94%
成長最快的細分市場 獸醫醫院和診所
最大的市場 北美洲

馬術運動和活動有著悠久的歷史,可以跨越幾個世紀,從古希臘的歷史性比賽到現代的奧林匹克盛裝舞步賽場。曾經的小眾興趣現已發展成為一種全球現象,數以百萬計的馬術愛好者參與了各種馬術項目。馬術參與度的激增不僅塑造了體育格局,也推動了全球馬匹醫療保健市場的成長。隨著馬術運動的興起,越來越多的人開始投資養馬。無論是競技性騎馬、休閒或陪伴,馬匹擁有量的增加都對馬匹醫療服務和產品產生了巨大的需求。馬主認知到需要確保馬匹伴侶的健康和福祉,並正在推動馬匹醫療保健市場的成長。不斷壯大的馬術社群提高了人們對馬匹健康和預防措施重要性的認知。馬主、騎手和馴馬師都知道,定期的獸醫檢查、疫苗接種和適當的營養對於保持馬匹處於最佳狀態至關重要。這種意識的提高推動了對馬匹醫療保健解決方案的需求,並鼓勵採取積極主動的馬匹護理方法。從地方比賽到國際錦標賽的馬術賽事吸引了大量觀眾和參與者。馬術障礙賽、盛裝舞步和牛仔競技等賽事擁有熱情的追隨者,吸引來自世界各地的騎手和愛好者。這些事件在馬術生態系統中產生了大量的經濟活動,導致對馬保健產品和服務的投資增加。隨著馬術運動的發展,對專業訓練和教練的需求也隨之而來。馴馬師和教練強調對馬匹進行適當護理和保健的重要性。這種教育不僅確保了動物的福祉,也推動了馬保健產品和服務的使用。馬術運動的發展刺激了馬匹醫療保健技術的進步。最先進的診斷工具、數位影像和先進的治療方案越來越容易獲得,從而提高了馬匹的護理品質。這些創新不僅有利於動物的健康,也吸引了馬主為他們的馬夥伴尋求最佳的醫療保健選擇。馬術世界極為多元化,涵蓋從賽馬到牛仔競技、三項賽和治療性馬術等廣泛的學科。這種多樣性促進了廣泛的馬匹醫療保健需求,從管理賽馬損傷到確保治療馬的健康。馬醫療保健市場正在不斷發展,以滿足每個學科的具體要求,進一步推動其成長。

目錄

第 1 章:產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章:研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章:執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章:客戶之聲

第 5 章:全球馬保健市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品(疫苗、藥品、藥用飼料添加劑、診斷、軟體和服務、其他)
    • 依適應症(肌肉骨骼疾病、寄生蟲控制、內科、馬皰疹病毒、馬腦​​脊髓炎、馬流感、西尼羅河病毒、破傷風、其他)
    • 按活動(運動/賽車、休閒、其他)
    • 按配銷通路(獸醫院和診所、電子商務、其他)
    • 按地區
    • 按公司分類 (2022)
  • 產品市場地圖
    • 按產品分類
    • 按指示
    • 按活動
    • 按配銷通路
    • 按地區

第 6 章:北美馬醫療保健市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品(疫苗、藥品、藥用飼料添加劑、診斷、軟體和服務、其他)
    • 依適應症(肌肉骨骼疾病、寄生蟲控制、內科、馬皰疹病毒、馬腦​​脊髓炎、馬流感、西尼羅河病毒、破傷風、其他)
    • 按活動(運動/賽車、休閒、其他)
    • 按配銷通路(獸醫院和診所、電子商務、其他)
    • 按國家/地區
  • 北美:國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章:歐洲馬保健市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品(疫苗、藥品、藥用飼料添加劑、診斷、軟體和服務、其他)
    • 依適應症(肌肉骨骼疾病、寄生蟲控制、內科、馬皰疹病毒、馬腦​​脊髓炎、馬流感、西尼羅河病毒、破傷風、其他)
    • 按活動(運動/賽車、休閒、其他)
    • 按配銷通路(獸醫院和診所、電子商務、其他)
    • 按國家/地區
  • 歐洲:國家分析
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙

第 8 章:亞太馬醫療保健市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品(疫苗、藥品、藥用飼料添加劑、診斷、軟體和服務、其他)
    • 依適應症(肌肉骨骼疾病、寄生蟲控制、內科、馬皰疹病毒、馬腦​​脊髓炎、馬流感、西尼羅河病毒、破傷風、其他)
    • 按活動(運動/賽車、休閒、其他)
    • 按配銷通路(獸醫院和診所、電子商務、其他)
    • 按國家/地區
  • 亞太地區:國家分析
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國

第 9 章:南美洲馬醫療保健市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品(疫苗、藥品、藥用飼料添加劑、診斷、軟體和服務、其他)
    • 依適應症(肌肉骨骼疾病、寄生蟲控制、內科、馬皰疹病毒、馬腦​​脊髓炎、馬流感、西尼羅河病毒、破傷風、其他)
    • 按活動(運動/賽車、休閒、其他)
    • 按配銷通路(獸醫院和診所、電子商務、其他)
    • 按國家/地區
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章:中東和非洲馬醫療保健市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品(疫苗、藥品、藥用飼料添加劑、診斷、軟體和服務、其他)
    • 依適應症(肌肉骨骼疾病、寄生蟲控制、內科、馬皰疹病毒、馬腦​​脊髓炎、馬流感、西尼羅河病毒、破傷風、其他)
    • 按活動(運動/賽車、休閒、其他)
    • 按配銷通路(獸醫院和診所、電子商務、其他)
    • 按國家/地區
  • MEA:國家分析
    • 南非馬匹保健
    • 沙烏地阿拉伯馬匹保健
    • 阿拉伯聯合大公國馬匹保健
    • 科威特馬匹保健

第 11 章:市場動態

  • 促進要素
  • 挑戰

第 12 章:市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章:波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章:競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務(據報導)
  • 主要人員
  • SWOT分析
    • Zoetis Inc.
    • Boehringer Ingelheim GmbH
    • Merck & Co., Inc.
    • Hallmarq Veterinary Imaging Ltd
    • Esaote SpA
    • Vetoquinol SA
    • IDEXX Laboratories, Inc.
    • Dechra Pharmaceuticals PLC

第 15 章:策略建議

第 16 章:關於我們與免責聲明

簡介目錄
Product Code: 17486

Global Equine Healthcare Market has valued at USD 2.52 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.94% through 2028. The global equine healthcare market refers to the industry dedicated to the health and well-being of horses. It encompasses a wide range of products and services designed to maintain and improve the health of horses, both for recreational and competitive purposes.

Key Market Drivers

Rising Participation in Equestrian Sports and Activities

Market Overview
Forecast Period2024-2028
Market Size 2022USD 2.52 Billion
Market Size 2028USD 3.55 Billion
CAGR 2023-20285.94%
Fastest Growing SegmentVeterinary Hospitals & Clinics
Largest MarketNorth America

Equestrian sports and activities have a rich history that spans centuries, from the historic races of ancient Greece to the modern arenas of Olympic dressage. What was once a niche interest has now evolved into a global phenomenon, with millions of enthusiasts participating in various equestrian disciplines. This surge in equestrian engagement is not only shaping the sports landscape but also driving the growth of the global equine healthcare market. As equestrian sports gain prominence, more people are investing in horse ownership. Whether for competitive riding, leisure, or companionship, this rise in horse ownership creates a significant demand for equine healthcare services and products. Horse owners, recognizing the need to ensure the health and well-being of their equine partners, are fueling the growth of the equine healthcare market. The growing equestrian community has fostered increased awareness of equine health and the importance of preventative measures. Horse owners, riders, and trainers understand that regular veterinary check-ups, vaccinations, and proper nutrition are essential to keeping their horses in peak condition. This heightened awareness drives the demand for equine healthcare solutions and encourages a proactive approach to horse care. Equestrian events, from local competitions to international championships, draw large audiences and participants. Events like show jumping, dressage, and rodeo have passionate followings, attracting riders and enthusiasts from around the world. These events generate substantial economic activity within the equestrian ecosystem, leading to increased investment in equine healthcare products and services. With the growth of equestrian sports comes a demand for specialized training and coaching. Trainers and coaches emphasize the importance of proper care and healthcare protocols for horses. This education not only ensures the well-being of the animals but also drives the use of equine healthcare products and services. The growth in equestrian sports has spurred technological advancements in equine healthcare. State-of-the-art diagnostic tools, digital imaging, and advanced treatment options are increasingly accessible, improving the quality of care for horses. These innovations are not only beneficial to the health of the animals but also attract horse owners seeking the best healthcare options for their equine companions. The equestrian world is incredibly diverse, encompassing a wide range of disciplines from racing to rodeo, eventing, and therapeutic riding. This diversity fosters a broad spectrum of equine healthcare needs, from managing injuries in racehorses to ensuring the well-being of therapy horses. The equine healthcare market is evolving to cater to the specific requirements of each discipline, further driving its growth.

Growing Awareness of Preventive Healthcare

In the world of equine health, prevention is not only better than cure; it's also an increasingly popular approach among horse owners and enthusiasts. As awareness of the importance of preventive healthcare continues to grow, it is emerging as a potent driver behind the expansion of the global equine healthcare market. The modern horse owner understands that good health is paramount to their horse's well-being and performance. This mindset shift from merely treating illnesses to actively preventing them has led to a surge in demand for preventive healthcare products and services. As equine healthcare takes center stage, the market responds with a wider array of preventative options. Preventive healthcare often begins with regular check-ups and vaccinations. Horse owners now appreciate the importance of scheduling routine veterinary visits to catch potential health issues before they escalate. This proactive approach ensures that horses remain in the best possible condition and minimizes the need for costly treatments down the road. Proper nutrition plays a critical role in preventing health problems in horses. Owners are increasingly seeking guidance on nutrition tailored to their horse's specific needs. This has led to a growing market for equine supplements, including vitamins, minerals, and joint support products, to keep horses in optimal condition. Equine parasites can pose significant health risks if left unchecked. Horse owners are now well-informed about the importance of parasite control through regular deworming and fecal testing. As a result, the demand for effective parasite control products has surged. Dental health is an integral aspect of preventive care. Regular dental check-ups and proper dental care can prevent issues like malocclusions and tooth decay. Dentists specializing in equine dental care are in high demand, contributing to the growth of the equine healthcare market. Maintaining a horse's physical fitness is another preventive strategy. Many horse owners now invest in exercise and conditioning programs that not only improve performance but also help prevent injuries and health issues. The internet and access to information have empowered horse owners to become more educated about equine health. Online resources, forums, and educational materials have made it easier for horse owners to stay informed and make informed decisions about their horse's healthcare.

Technological Advancements in Diagnostics and Treatment

In the realm of equine health, innovation knows no bounds. With the rapid evolution of diagnostic tools and treatment technologies, the global equine healthcare market is galloping ahead like never before. This surge in technological advancements has not only transformed the landscape of equine medicine but also contributed significantly to the growth of this vital industry. One of the most significant benefits of technological advancements in equine healthcare is the improvement of diagnostic accuracy. State-of-the-art diagnostic tools, such as digital radiography, magnetic resonance imaging (MRI), and ultrasound, provide veterinarians with clear and precise images of a horse's internal structures. This allows for early detection of health issues, resulting in quicker and more effective treatment, and ultimately reducing the risk of complications. In the digital age, telemedicine has become a game-changer in equine healthcare. Veterinarians can now offer consultations, monitor a horse's condition, and provide guidance remotely, saving time and improving access to expert care. This technology is particularly valuable for horse owners in remote areas or those facing logistical challenges. Technological advancements have also revolutionized equine surgery. Minimally invasive procedures, including arthroscopy and laparoscopy, have reduced the trauma and recovery time associated with traditional surgeries. Horses can return to their normal activities more swiftly, benefiting both their owners and the equine healthcare market. Regenerative medicine is another exciting frontier in equine healthcare. Treatments like stem cell therapy and platelet-rich plasma (PRP) have shown promise in accelerating the healing of injuries and degenerative conditions. These regenerative therapies offer new avenues for treatment and recovery, driving demand within the market.

Expanding Disposable Income

The world of equine healthcare is experiencing a transformation, driven in part by a significant and widespread trend: the expansion of disposable income. As economies prosper and individuals and families enjoy greater financial stability, horse ownership and participation in equestrian activities have become more accessible and affordable. This shift in economic dynamics is not only reshaping the equine landscape but also boosting the growth of the global equine healthcare market. Expanding disposable income has made horse ownership more achievable for a broader demographic. What was once a luxury reserved for a select few is now within reach for many individuals and families. This democratization of horse ownership has resulted in a surge in the number of horses worldwide, increasing the demand for equine healthcare products and services. As disposable income grows, so does the inclination to invest in recreational pursuits. Horses have transitioned from traditional roles in farming and transportation to becoming valued companions and recreational partners. This shift has led to greater expenditure on equine care, including preventive healthcare, nutrition, and veterinary services. With higher income levels, horse owners are more willing to invest in premium products and services for their equine companions. This includes high-quality feed and supplements, top-notch veterinary care, advanced diagnostics, and specialized treatments. As a result, the equine healthcare market has expanded to meet the demand for these premium offerings. Expanding disposable income has led to increased participation in equestrian sports and activities. Individuals and families can now afford riding lessons, horse training, and participation in competitive events. The more horses are involved in these activities, the greater the demand for equine healthcare solutions to ensure their performance and well-being. Higher disposable income has shifted the focus from mere horse ownership to the well-being and longevity of equine companions. Horse owners are more willing to invest in preventive healthcare measures, regular check-ups, dental care, and nutritional plans to ensure their horses lead healthy, fulfilling lives.

Key Market Challenges

High Cost of Specialized Care

One of the foremost challenges in the equine healthcare market is the high cost associated with specialized care. Horses, unlike smaller companion animals, often require specialized veterinary services, medications, and equipment, all of which come at a premium. This can deter some horse owners from seeking proper care, potentially compromising the health of their animals.

Limited Availability of Skilled Veterinarians

Equine veterinarians are a specialized breed themselves, and their numbers can be limited in some regions. Finding qualified and experienced equine veterinarians can be challenging, especially in rural areas. This scarcity can lead to delays in care and potentially inadequate treatment.

Resistance to Change

Despite advancements in equine healthcare, some horse owners and trainers may resist adopting new practices or technologies. Tradition often plays a significant role in horse care, and convincing stakeholders to embrace innovation can be a gradual process.

Cost-Effective Alternatives

While some horse owners are willing to invest significantly in their animals' health, others may seek cost-effective alternatives. This can lead to the use of less proven or non-veterinary approaches to healthcare, potentially putting horses at risk.

Key Market Trends

Telemedicine and Remote Monitoring

Telemedicine is rapidly gaining traction in the equine healthcare industry. Horse owners and veterinarians are increasingly using digital platforms to facilitate remote consultations, monitor vital signs, and manage health records. This trend enhances convenience, reduces travel stress for horses, and allows for prompt assessment and intervention, particularly in remote areas.

Precision Medicine and Personalized Care

The equine healthcare market is moving towards a more personalized approach. Advances in genetics and diagnostics enable tailored treatments and nutrition plans for individual horses. Precision medicine ensures that each horse receives care specifically designed to meet its unique needs, optimizing health and performance.

Regenerative Therapies

Regenerative therapies, such as stem cell treatments and platelet-rich plasma (PRP) therapy, are gaining prominence in the equine healthcare sector. These innovative treatments offer the potential to accelerate healing, manage musculoskeletal issues, and improve overall well-being in horses. As research continues, regenerative therapies are likely to become more accessible and widely adopted.

Wearable Health Monitoring Devices

Wearable technology is making its mark in equine healthcare. Equipped with sensors and trackers, wearable devices monitor vital signs, movement, and behavior in real-time. These devices provide valuable data for veterinarians and horse owners to assess health, track performance, and detect issues early.

Segmental Insights

Product Insights

Based on the category of Product, the pharmaceutical industry held a dominant position in the market in 2022. Various types of pharmaceutical products designed for horses, including pain relievers, anti-infectives, anti-inflammatory drugs, and parasiticides, were widely used to address a range of equine health issues, such as reproductive, metabolic, infectious, and dermatological disorders. The market for both prescription and non-prescription medications experienced significant growth, driven by increased spending on equestrian activities and overall equine healthcare. This growth can be attributed to the efforts made by industry players. For example, Zoetis offered a comprehensive selection of medications, including equine parasiticides like QUEST gel, Equest Pramox, Deosect 5% Spray Solution, and more.

Looking ahead, the "others" category is expected to exhibit the highest growth rate from 2023 to 2030. This category encompasses regenerative treatments for horses, such as stem cell therapy, among others. The growth of this segment is anticipated to be fueled by increased research and development activities in the field of equine medicine. In June 2021, Zoetis introduced a range of devices, including Pro-Stride APS, CenTrate BMA, and Restigen PRP, designed to assist in the treatment of injuries in horses that can lead to lameness. These devices simplify the processing of horses' blood or bone marrow, eliminating the need for incubation or off-site preparation and enabling immediate use after centrifugation.

Indication Insights

In 2022, the dominant focus within the market was on controlling parasites. Parasiticides, which encompass treatments for both external parasites (ectoparasiticides) and internal parasites (endoparasiticides), were available in various forms such as sprays, collars, oral solutions, gels, and spot-on treatments. They could be administered through topical, oral, or intravenous methods and were effective in addressing health issues caused by amoebas, helminths, protozoa, and parasitic fungi.

Looking ahead, the segment related to equine influenza is expected to experience the most rapid growth during the forecast period. This growth can be attributed to the increasing prevalence of infectious diseases in horses. According to the OIE (World Organisation for Animal Health), there were more than 12,000 reported cases of equine influenza worldwide between 2017 and 2021. The demand for equine healthcare is on the rise due to mounting pressure to maintain the health of horses and optimize their performance, especially in the case of race and sports horses. Additionally, there is a growing awareness of the importance of preventive measures against equine diseases.

Regional Insights

In 2022, North America held the largest market share. According to data from the FAO (Food and Agriculture Organization), the United States alone had approximately 10.56 million horses in 2021, and the broader North American region boasted around 10.96 million horses. This substantial share was further bolstered by the presence of numerous horse farms and an extensive annual calendar of horse races. The United States, for instance, boasts approximately 300 racetracks, hosting nearly 33,567 horse races each year. Additionally, the importation of an estimated 18,865 horses into the U.S. in 2021 contributed to the demand for equine healthcare in North America.

Looking ahead, the Asia-Pacific (APAC) region is projected to experience the most rapid growth during the forecast period. This growth can be attributed to several factors, including an increased demand for medicinal horse feeds, a rise in the prevalence of equine diseases, and government initiatives aimed at promoting equine health. Furthermore, the presence of numerous market participants operating in the equine products sector is expected to exert a significant influence on market growth in the coming years.

Key Market Players

Zoetis Inc.

Boehringer Ingelheim GmbH

Merck & Co., Inc.

Hallmarq Veterinary Imaging Ltd

Esaote SpA

Vetoquinol SA

IDEXX Laboratories, Inc.

Dechra Pharmaceuticals PLC

Report Scope:

In this report, the Global Equine Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Healthcare Market, By Product:

  • Vaccines
  • Pharmaceuticals
  • Medicinal Feed Additives
  • Diagnostics
  • Software & Services
  • Others

Equine Healthcare Market, By Indication:

  • Musculoskeletal Disorders
  • Parasite Control
  • Internal Medicine
  • Equine Herpes Virus
  • Equine Encephalomyelitis
  • Equine Influenza
  • West Nile Virus
  • Tetanus
  • Others

Equine Healthcare Market, By Activity:

  • Sports/Racing
  • Recreation
  • Others

Equine Healthcare Market, By Distribution Channel:

  • Veterinary Hospitals & Clinics
  • E-commerce
  • Others

Equine Healthcare Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Equine Healthcare Market.

Available Customizations:

  • Global Equine Healthcare market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Equine Healthcare Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
    • 5.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
    • 5.2.3. By Activity (Sports/Racing, Recreation, Others)
    • 5.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Product Market Map
    • 5.3.1. By Product
    • 5.3.2. By Indication
    • 5.3.3. By Activity
    • 5.3.4. By Distribution Channel
    • 5.3.5. By Region

6. North America Equine Healthcare Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
    • 6.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
    • 6.2.3. By Activity (Sports/Racing, Recreation, Others)
    • 6.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Equine Healthcare Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Indication
        • 6.3.1.2.3. By Activity
        • 6.3.1.2.4. By Distribution Channel
    • 6.3.2. Canada Equine Healthcare Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Indication
        • 6.3.2.2.3. By Activity
        • 6.3.2.2.4. By Distribution Channel
    • 6.3.3. Mexico Equine Healthcare Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Indication
        • 6.3.3.2.3. By Activity
        • 6.3.3.2.4. By Distribution Channel

7. Europe Equine Healthcare Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
    • 7.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
    • 7.2.3. By Activity (Sports/Racing, Recreation, Others)
    • 7.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Equine Healthcare Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By Activity
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. United Kingdom Equine Healthcare Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By Activity
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. France Equine Healthcare Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By Activity
        • 7.3.3.2.4. By Distribution Channel
    • 7.3.4. Italy Equine Healthcare Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Indication
        • 7.3.4.2.3. By Activity
        • 7.3.4.2.4. By Distribution Channel
    • 7.3.5. Spain Equine Healthcare Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Indication
        • 7.3.5.2.3. By Activity
        • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Equine Healthcare Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
    • 8.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
    • 8.2.3. By Activity (Sports/Racing, Recreation, Others)
    • 8.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Equine Healthcare Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By Activity
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. Japan Equine Healthcare Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By Activity
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. India Equine Healthcare Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By Activity
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. Australia Equine Healthcare Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By Activity
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. South Korea Equine Healthcare Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By Activity
        • 8.3.5.2.4. By Distribution Channel

9. South America Equine Healthcare Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
    • 9.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
    • 9.2.3. By Activity (Sports/Racing, Recreation, Others)
    • 9.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Equine Healthcare Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By Activity
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. Argentina Equine Healthcare Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By Activity
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Colombia Equine Healthcare Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By Activity
        • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Equine Healthcare Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
    • 10.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
    • 10.2.3. By Activity (Sports/Racing, Recreation, Others)
    • 10.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Equine Healthcare Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By Activity
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Saudi Arabia Equine Healthcare Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By Activity
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. UAE Equine Healthcare Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By Activity
        • 10.3.3.2.4. By Distribution Channel
    • 10.3.4. Kuwait Equine Healthcare Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Indication
        • 10.3.4.2.3. By Activity
        • 10.3.4.2.4. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
  • 14.6. SWOT Analysis
    • 14.6.1. Zoetis Inc.
    • 14.6.2. Boehringer Ingelheim GmbH
    • 14.6.3. Merck & Co., Inc.
    • 14.6.4. Hallmarq Veterinary Imaging Ltd
    • 14.6.5. Esaote SpA
    • 14.6.6. Vetoquinol SA
    • 14.6.7. IDEXX Laboratories, Inc.
    • 14.6.8. Dechra Pharmaceuticals PLC

15. Strategic Recommendations

16. About Us & Disclaimer